LOPROX
LOE ApproachingNDATOPICALSHAMPOO
Approved
Feb 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4d ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOPROX is a topical antifungal shampoo approved in 2003 for treating fungal scalp infections. The product is formulated for direct application to affected areas and works through topical antifungal mechanisms. It is a mature, well-established dermatology product.
LOE Approaching
Competitive pressure is moderate (30% rating), suggesting market maturation and likely smaller team size focused on retention and life-cycle extension rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LOPROX offers exposure to lifecycle management, competitive positioning, and transition strategy in a mature dermatology franchise. Career growth on this product is limited; success is measured by market share defense and operational efficiency rather than expansion.
Brand ManagerProduct Manager
Worked on LOPROX at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.